494 related articles for article (PubMed ID: 27133416)
21. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
22. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
[TBL] [Abstract][Full Text] [Related]
23. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Oechsner M; Korchounov A
Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
[TBL] [Abstract][Full Text] [Related]
24. [Withdrawal versus continuation of antipsychotic drugs in people with dementia].
Lolk A
Ugeskr Laeger; 2014 Jul; 176(31):. PubMed ID: 25292325
[TBL] [Abstract][Full Text] [Related]
25. Zuclopenthixol acetate in a demented elderly patient with agitation.
Myronuk L; Geizer M; Ancill RJ
Can J Psychiatry; 1997 Apr; 42(3):325. PubMed ID: 9114954
[No Abstract] [Full Text] [Related]
26. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
[TBL] [Abstract][Full Text] [Related]
27. Liquid risperidone in the treatment of psychotic agitation.
Tsai C; Puzantian T
CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
[No Abstract] [Full Text] [Related]
28. The treatment of behavioral disturbances and psychosis associated with dementia.
Lochhead JD; Nelson MA; Maguire GA
Psychiatr Pol; 2016; 50(2):311-22. PubMed ID: 27288676
[TBL] [Abstract][Full Text] [Related]
29. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
[TBL] [Abstract][Full Text] [Related]
30. [State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].
Haffen E; Sechter D
Rev Prat; 1998 May; 48(10):1123-7. PubMed ID: 9781159
[No Abstract] [Full Text] [Related]
31. Current attitudes regarding treatment of agitation and psychosis in dementia.
Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
[No Abstract] [Full Text] [Related]
32. [Treatment of agitation in dementia patients].
González Salvador MT; Arango López C; Lyketsos CG
Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
[No Abstract] [Full Text] [Related]
33. First generation antipsychotic-induced severe hypothermia: A case report and review of the literature.
Elbakary NAH; Ouanes S
Asian J Psychiatr; 2019 Aug; 44():35-37. PubMed ID: 31306860
[No Abstract] [Full Text] [Related]
34. The emergency treatment of depression complicated by psychosis or agitation.
Glick RL; Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute agitation in psychotic disorders.
Mohr P; Pecenák J; Svestka J; Swingler D; Treuer T
Neuro Endocrinol Lett; 2005 Aug; 26(4):327-35. PubMed ID: 16136016
[TBL] [Abstract][Full Text] [Related]
36. New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis.
Stahl SM
CNS Spectr; 2018 Oct; 23(5):291-297. PubMed ID: 30382934
[TBL] [Abstract][Full Text] [Related]
37. Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
Wilkins JM; Forester BP
Curr Psychiatry Rep; 2016 Feb; 18(2):14. PubMed ID: 26781552
[TBL] [Abstract][Full Text] [Related]
38. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
39. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
Schneider LS; Ismail MS; Dagerman K; Davis S; Olin J; McManus D; Pfeiffer E; Ryan JM; Sultzer DL; Tariot PN
Schizophr Bull; 2003; 29(1):57-72. PubMed ID: 12908661
[TBL] [Abstract][Full Text] [Related]
40. Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.
Devanand DP; Pelton GH; D'Antonio K; Strickler JG; Kreisl WC; Noble J; Marder K; Skomorowsky A; Huey ED
Alzheimer Dis Assoc Disord; 2017; 31(1):73-75. PubMed ID: 27819842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
